Sorrento Therape
Biotechnology
Healthcare
SRNE
337 M shares
NASDAQ US
traded
25 Nov 2022
listed
yes
open
1.37
52 week high
6.47
high
1.40
52 week low
1.34
low
1.35
growth
-72.73 %
previous Close
1.38
P/E ratio
market cap
980 M
div yield
0
usd
Jun 2022
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
-350.00 %
eps surprise
-116.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
-41.56 M
-154.44 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top